Benzinga's Top Upgrades - BioCryst Pharma (NASDAQ:BCRX), HSBC Holdings (NYSE:HSBC)

Analysts at BTIG Research upgraded

Synchrony FinancialSYF

from Neutral to Buy. Synchrony Financial shares closed at $30.52 on Friday. Bank of America upgraded

BioCryst Pharmaceuticals, Inc. BCRX

from Underperform to Neutral. Biocryst Pharmaceuticals shares closed at $9.78 on Friday. Analysts at Deutsche Bank upgraded

RenaissanceRe Holdings Ltd. RNR

from Hold to Buy. The price target for RenaissanceRe Holdings has been raised from $107 to $116. RenaissanceRe Holdings shares closed at $101.55 on Friday. Analysts at Susquehanna upgraded

Intersil CorpISIL

from Neutral to Positive. Intersil shares closed at $14.41 on Friday. BC Capital upgraded

Unilever N.V. (ADR) UN

from Sector Perform to Outperform. Unilever shares closed at $44.37 on Friday. Analysts at Goldman Sachs upgraded

HSBC HoldingsHSBC

from Buy to Conviction Buy.. The price target for HSBC Holdings has been raised from $34 to $37. HSBC Holdings shares closed at $44.86 on Friday. Jefferies upgraded

Symantec CorporationSYMC

from Underperform to Hold. Symantec shares closed at $24.24 on Friday. RBC Capital upgraded

Selective Insurance GroupSIGI

from Sector Perform to Outperform. The price target for Selective Insurance is set to $29. Selective Insurance shares closed at $27.90 on Friday.

Market News and Data brought to you by Benzinga APIs